MedTrace Logo

FAPI PET/CT Prospective Interobserver Agreement

NCT04990882 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2022-11-03

No results posted yet for this study

Summary

The aim of the present study is to evaluate the interobserver agreement for FAPI PET/CT interpretations of representative cancer types and compare findings among readers with different levels of experience.

Conditions

  • Malignant Neoplasm

Interventions

OTHER

Interpretation of FAPI-PET/CT scans

Each observer's Group will be asked to review FAPI-PET/CT scans of patients with representative cancer types.

Sponsors & Collaborators

  • University Hospital, Essen

    lead OTHER

Principal Investigators

  • Wolfgang Fendler, MD · Study Principal Investigator

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-10-30
Completion
2022-10-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04990882 on ClinicalTrials.gov